Limited adherence to safety instructions in drug leaflets

被引：3

作者：

Derijks, HJ

de Koning, GHP

Mantel-Teeuwisse, AK

Egberts, ACG

机构：

[1] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmacoepidemiol & Pharmacotherapy, NL-3508 TB Utrecht, Netherlands

[2] Community Pharm Venloon, Loon Op Zand, Netherlands

[3] TweeSteden Hosp, Hosp Pharm Midden Brabant, Tilburg, Netherlands

[4] St Elizabeth Hosp, Tilburg, Netherlands

来源：

关键词：

D O I：

10.1046/j.1365-2125.2002.01701.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：678 / 679

页数：2

共 6 条

[1] Learning from the cerivastatin experience [J].

Farmer, JA .

[2]

Honig P, 2000, JAMA-J AM MED ASSOC, V284, P2187

[3]

HONIG P, 2000, JAMA-J AM MED ASSOC, V284, P2188

[4] Validation of pharmacy records in drug exposure assessment [J].

Lau, HS ;

deBoer, A ;

Beuning, KS ;

Porsius, A .

[5] FDA adverse event reports on statin-associated rhabdomyolysis [J].

Omar, MA ;

Wilson, JP .

[6] Drug labeling revisions - Guaranteed to fail? [J].

Woosley, RL .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (23) :3047-3049